vs
先锋自然资源公司（PR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
先锋自然资源公司的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 29.0%，领先5.4%），Royalty Pharma plc同比增速更快（4.8% vs -9.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -3.0%）
先锋自然资源公司总部位于美国得克萨斯州欧文市，主要从事油气勘探业务，运营覆盖二叠纪盆地Spraberry产区的克莱恩页岩区块，是该区域最大的土地权益持有方，2024年5月被埃克森美孚收购。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PR vs RPRX — 直观对比
营收规模更大
PR
是对方的1.9倍
$622.0M
营收增速更快
RPRX
高出14.6%
-9.8%
净利率更高
RPRX
高出5.4%
29.0%
两年增速更快
RPRX
近两年复合增速
-3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $339.5M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 23.1% | 62.4% |
| 净利率 | 29.0% | 34.4% |
| 营收同比 | -9.8% | 4.8% |
| 净利润同比 | 56.7% | 2.9% |
| 每股收益（稀释后） | $0.48 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRRPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.3B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.4B | $568.2M | ||
| Q4 24 | $1.3B | $593.6M | ||
| Q3 24 | $1.2B | $564.7M | ||
| Q2 24 | $1.2B | $537.3M | ||
| Q1 24 | $1.2B | $568.0M |
净利润PRRPRX
| Q4 25 | $339.5M | $214.2M | ||
| Q3 25 | $59.2M | $288.2M | ||
| Q2 25 | $207.1M | $30.2M | ||
| Q1 25 | $329.3M | $238.3M | ||
| Q4 24 | $216.7M | $208.2M | ||
| Q3 24 | $386.4M | $544.0M | ||
| Q2 24 | $235.1M | $102.0M | ||
| Q1 24 | $146.6M | $4.8M |
营业利润率PRRPRX
| Q4 25 | 23.1% | 62.4% | ||
| Q3 25 | 29.6% | 70.1% | ||
| Q2 25 | 24.8% | 36.3% | ||
| Q1 25 | 36.6% | 94.0% | ||
| Q4 24 | 32.8% | 60.9% | ||
| Q3 24 | 32.5% | — | ||
| Q2 24 | 36.5% | 50.2% | ||
| Q1 24 | 37.7% | -13.0% |
净利率PRRPRX
| Q4 25 | 29.0% | 34.4% | ||
| Q3 25 | 4.5% | 47.3% | ||
| Q2 25 | 17.3% | 5.2% | ||
| Q1 25 | 23.9% | 41.9% | ||
| Q4 24 | 16.7% | 35.1% | ||
| Q3 24 | 31.8% | 96.3% | ||
| Q2 24 | 18.9% | 19.0% | ||
| Q1 24 | 11.8% | 0.8% |
每股收益（稀释后）PRRPRX
| Q4 25 | $0.48 | $0.49 | ||
| Q3 25 | $0.08 | $0.67 | ||
| Q2 25 | $0.28 | $0.07 | ||
| Q1 25 | $0.44 | $0.55 | ||
| Q4 24 | $0.31 | $0.46 | ||
| Q3 24 | $0.53 | $1.21 | ||
| Q2 24 | $0.36 | $0.23 | ||
| Q1 24 | $0.25 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $153.7M | $618.7M |
| 总债务越低越好 | $3.5B | $9.0B |
| 股东权益账面价值 | $10.3B | $9.7B |
| 总资产 | $17.9B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.34× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PRRPRX
| Q4 25 | $153.7M | $618.7M | ||
| Q3 25 | $111.8M | $938.9M | ||
| Q2 25 | $451.0M | $631.9M | ||
| Q1 25 | $702.2M | $1.1B | ||
| Q4 24 | $479.3M | $929.0M | ||
| Q3 24 | $272.0M | $950.1M | ||
| Q2 24 | $47.8M | $1.8B | ||
| Q1 24 | $12.7M | $843.0M |
总债务PRRPRX
| Q4 25 | $3.5B | $9.0B | ||
| Q3 25 | $3.5B | $8.9B | ||
| Q2 25 | $4.0B | $8.0B | ||
| Q1 25 | $4.0B | $7.6B | ||
| Q4 24 | $4.2B | $7.6B | ||
| Q3 24 | $4.2B | $7.6B | ||
| Q2 24 | $3.9B | $7.6B | ||
| Q1 24 | $3.9B | $6.1B |
股东权益PRRPRX
| Q4 25 | $10.3B | $9.7B | ||
| Q3 25 | $10.0B | $9.6B | ||
| Q2 25 | $9.5B | $9.5B | ||
| Q1 25 | $9.4B | $9.8B | ||
| Q4 24 | $9.1B | $10.3B | ||
| Q3 24 | $9.0B | $10.3B | ||
| Q2 24 | $8.3B | $9.8B | ||
| Q1 24 | $7.0B | $9.9B |
总资产PRRPRX
| Q4 25 | $17.9B | $19.6B | ||
| Q3 25 | $17.3B | $19.3B | ||
| Q2 25 | $17.5B | $18.3B | ||
| Q1 25 | $17.1B | $17.6B | ||
| Q4 24 | $16.9B | $18.2B | ||
| Q3 24 | $16.6B | $18.0B | ||
| Q2 24 | $15.4B | $17.7B | ||
| Q1 24 | $15.1B | $16.1B |
负债/权益比PRRPRX
| Q4 25 | 0.34× | 0.92× | ||
| Q3 25 | 0.35× | 0.93× | ||
| Q2 25 | 0.42× | 0.84× | ||
| Q1 25 | 0.43× | 0.78× | ||
| Q4 24 | 0.46× | 0.74× | ||
| Q3 24 | 0.47× | 0.74× | ||
| Q2 24 | 0.46× | 0.78× | ||
| Q1 24 | 0.56× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $904.3M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 2.66× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PRRPRX
| Q4 25 | $904.3M | $827.1M | ||
| Q3 25 | $766.5M | $702.6M | ||
| Q2 25 | $1.0B | $364.0M | ||
| Q1 25 | $898.0M | $596.1M | ||
| Q4 24 | $871.6M | $742.5M | ||
| Q3 24 | $954.4M | $703.6M | ||
| Q2 24 | $938.4M | $658.2M | ||
| Q1 24 | $647.6M | $664.6M |
现金转化率PRRPRX
| Q4 25 | 2.66× | 3.86× | ||
| Q3 25 | 12.94× | 2.44× | ||
| Q2 25 | 5.01× | 12.06× | ||
| Q1 25 | 2.73× | 2.50× | ||
| Q4 24 | 4.02× | 3.57× | ||
| Q3 24 | 2.47× | 1.29× | ||
| Q2 24 | 3.99× | 6.45× | ||
| Q1 24 | 4.42× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PR
| Crude Oil | $1.0B | 87% |
| Natural Gas Liquids Reserves | $145.1M | 12% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
